![Bryan Kobel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryan Kobel
Directeur Général chez
TC BIOPHARM (HOLDINGS) PLC
Fortune : - $ au 31/03/2026
Profil
Bryan Kobel currently works at TC Biopharm (Holdings) Plc, as Chief Executive Officer & Director from 2021, TCB Newco Ltd., as CEO-Biopharm North America, TC BioPharm (North America), Inc., as Chief Executive Officer from 2021, and TC BioPharm Ltd., as Chief Executive Officer & Director from 2021.
Mr. Kobel also formerly worked at Laidlaw & Co. (UK) Ltd., as Managing Director from 2012 to 2017, The Alberleen Group LLC, as Managing Director from 2018 to 2020, R.F.
Lafferty & Co., Inc., as Head-Capital Markets from 2017 to 2018, and HUTN, Inc., as Head-Healthcare Investment Banking.
Mr. Kobel received his undergraduate degree from Franklin & Marshall College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/05/2025 | 476 154 ( 16,41% ) | - $ | 31/03/2026 |
Postes actifs de Bryan Kobel
| Sociétés | Poste | Début |
|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Directeur Général | 01/06/2021 |
TC BioPharm (North America), Inc. | Directeur Général | 01/06/2021 |
TC Biopharm Ltd.
 TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research services | Directeur Général | 01/06/2021 |
Anciens postes connus de Bryan Kobel
| Sociétés | Poste | Fin |
|---|---|---|
TCB Newco Ltd.
 TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Corporate Officer/Principal | 07/02/2023 |
The Alberleen Group LLC
 The Alberleen Group LLC Investment Banks/BrokersFinance Provides investment banking services | Corporate Officer/Principal | 01/10/2020 |
R.F. Lafferty & Co., Inc.
 R.F. Lafferty & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/06/2018 |
Laidlaw & Co. (UK) Ltd.
 Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Provides investment advice | Corporate Officer/Principal | 01/04/2017 |
| HUTN, INC. | Corporate Officer/Principal | - |
Formation de Bryan Kobel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
R.F. Lafferty & Co., Inc.
R.F. Lafferty & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
HUTN, Inc.
 HUTN, Inc. Investment ManagersFinance Operates as a holding company whose subsidiaries provides investment advice, online trade execution and digital financial products | Finance |
Franklin & Marshall College
 Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Provides investment advice | Finance |
TC Biopharm Ltd.
TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research services | Commercial Services |
The Alberleen Group LLC
The Alberleen Group LLC Investment Banks/BrokersFinance Provides investment banking services | Finance |
TC Biopharm (Holdings) Plc
 TC Biopharm (Holdings) Plc BiotechnologyHealth Technology Operates as a holding company through it's subsidiaries develops clinical-stage cell therapies | Health Technology |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
TC BioPharm (North America), Inc. |
